News Chart Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Market Closed - OTC Markets Other stock markets 01:19:11 17/05/2024 am IST			5-day change	1st Jan Change
0.0007 ^USD	0.00%		-30.00%	-94.17%

16/04	Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	CI
16/04	Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC	CI

96b81d5f216e0914a84a1bb.FjxjRjJ3krY63q29k8CNO1O7Yq8fjyKbVmAMsW1j4c8.TGYMEmZExO5-rfnV_Y3iVwLKMd0n9XDBIC9FhAwn1P9iCwQKSiTK01Cp7A~5a0a17ff26c3a6a677d8546deb72243c